MINI FUTURE LONG - UCB Share Price

QH82B

NL0012040141

Real-time Euronext Paris 14:03:17 24/06/2024 BST
87.52 ^EUR	-1.98%

Current month	+13.63%
1 month	+13.98%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project	06-20	BU
Kepler Cheuvreux Downgrades UCB to Hold from Buy, Raises PT	06-20	MT
UCB : Financial Reporting Document	06-15	PU
UCB Announces New CIMZIA® Data for Women Living with Chronic Rheumatic Diseases Throughout Pregnancy, and for People Living with Ra and High Rheumatoid Factor Levels	06-13	CI

More news

Quotes 5-day view

Date	Price	Change
24/06/24	87.52	-1.98%
21/06/24	89.29	+2.74%
20/06/24	86.91	-2.51%
19/06/24	89.15	+0.13%
18/06/24	89.03	+1.57%

Real-time Euronext Paris

Last update June 24, 2024 at 02:03 pm

More quotes

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	QH82B
ISIN	NL0012040141
Date issued	13/12/2016
Strike	50.26 €
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	89.67 €
Lowest since issue	7.72 €
Spread	0.1 €
Spread %	0.11%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

139.1 EUR

Average target price

137.9 EUR

Spread / Average Target

-0.89%

Consensus